<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000903.v1.p1" parentStudy="phs000903.v1.p1" createDate="2015-04-22" modDate="2015-04-24">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigators</td><td>Gerald Nestadt</td><td>Johns Hopkins University, Baltimore, MD, USA</td></tr>
		<tr><td>Principal Investigators</td><td>Abby Fyer</td><td>Columbia University, New York, NY, USA</td></tr>
		<tr><td>Principal Investigators</td><td>Daniel Geller</td><td>Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA</td></tr>
		<tr><td>Principal Investigators</td><td>James Knowles</td><td>University of Southern California, Los Angeles, CA, USA</td></tr>
		<tr><td>Principal Investigators</td><td>James McCracken</td><td>University of California, Los Angeles, Los Angeles, CA, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>OCD Collaborative Genetic Association Study (OCGAS)</StudyNameEntrez>
	<StudyNameReportPage>OCD Collaborative Genetic Association Study (OCGAS)</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Parent-Offspring Trios</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>The OCD Collaborative Genetics Association Study Group (OCGAS) was funded by NIMH to conduct a genome-wide association study to identify disease susceptibility loci of early-onset obsessive-compulsive disorder (OCD). Collaborators at Johns Hopkins, Brown, Columbia, MGH, UCLA, and NIMH evaluated 2,000 individuals with OCD and collected DNA from these individuals and both their parents. The genotyping and analyses was performed in two stages. In the first stage 1,065 families (comprising 1406 patients with OCD and 2895 individuals in total) were genotyped on the Illumina OmniExpress GWA (SNPs) panel at the JHU SNP Center.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>Probands were required to meet DSM-IV criteria for OCD with onset of obsessions and/or compulsions before the age of 18 years.</p> <p>Subjects with brain disease, schizophrenia, severe mental retardation that does not permit an evaluation to characterize the psychiatric disorder, Tourette disorder (TS), or OCD occurring exclusively in the context of depression (secondary OCD) were excluded.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="24821223"/>
		</Publication>
		<Publication>
			<Pubmed pmid="25824302"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Obsessive-Compulsive Disorder"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigators">
			<AttName>Gerald Nestadt</AttName>
			<Institution>Johns Hopkins University, Baltimore, MD, USA</Institution>
		</Header>
		<Header title="Principal Investigators">
			<AttName>Abby Fyer</AttName>
			<Institution>Columbia University, New York, NY, USA</Institution>
		</Header>
		<Header title="Principal Investigators">
			<AttName>Daniel Geller</AttName>
			<Institution>Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA</Institution>
		</Header>
		<Header title="Principal Investigators">
			<AttName>James Knowles</AttName>
			<Institution>University of Southern California, Los Angeles, CA, USA</Institution>
		</Header>
		<Header title="Principal Investigators">
			<AttName>James McCracken</AttName>
			<Institution>University of California, Los Angeles, Los Angeles, CA, USA</Institution>
		</Header>
		<Header title="Funding Source - Gerald Nestadt">
			<AttName>R01MH071507</AttName>
			<Institution>National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source - Abby Fyer">
			<AttName>R01MH079488</AttName>
			<Institution>National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source - Daniel Geller">
			<AttName>R01MH079489</AttName>
			<Institution>National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source - James Knowles">
			<AttName>R01MH079494</AttName>
			<Institution>National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source - James McCracken">
			<AttName>R01MH079487</AttName>
			<Institution>National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="0" shortName="NRUP" longName="Subjects did not participate in the study, did not complete a consent document and are included only for the pedigree structure and/or genotype controls, such as HapMap subjects"/>
		<ConsentGroup groupNum="1" shortName="DS-OCD-OPC" longName="Disease-Specific (Obsessive Compulsive Disorder and other psychiatric conditions)"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NIMH</DacName>
      <DacFullName>NIMH</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000903.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000903.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000903.v1.p1" FileName=""/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Disease-Specific (Obsessive Compulsive Disorder and other psychiatric conditions)</ConsentName>
        <ConsentAbbrev>DS-OCD-OPC</ConsentAbbrev>
        <UseLimitation>Use of the data must be related to Obsessive Compulsive Disorder and other psychiatric conditions.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>

<Analyses>
	<Analysis pha="3885" genomeBuild="38" snpBuild="141" analysisType="">
		<Description>The aim of the OCD Collaborative Genetics Association Study (OCGAS) was to identify common variants associated with OCD using an integrative analyses pipeline that involved association testing at both SNP and gene levels. A total of 1065 families were included in this study (comprising 1406 patients with OCD and 2895 individuals in total). Genotyping was performed at the Johns Hopkins SNP Center using Illumina&#8217s HumanOmniExpress bead chips (Illumina, San Diego, CA, USA)</Description>
		<Method>categorical trait analysis</Method>
		<GtyPlatform probeNum="747309" snpBatchId="1056552">
			<Vendor>Illumina</Vendor>
			<VendorURL>HumanOmniExpress-12v1_H</VendorURL>
			<Platform>HumanOmniExpress-12v1_C</Platform>
		</GtyPlatform>
		<Comment></Comment>
	</Analysis>
</Analyses>

</Study>

</Studies>

</GaPExchange>
